← All trials
NCT02061475
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Mar 1, 2015
- Completion date
- Mar 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Jiao Tong UniversityLead sponsor
- Nitto Denko CorporationCollaborator
- Giant Med-Pharma Services Inc.Collaborator
- Jiao Tong UniversityOverall official - principal investigator
- Jiao Tong UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.